TOP >>Main Part 2012 >>2-2 >>Radiology
Radiology |
Director NAGANAWA, Shinji (Professor) 3E |
Our department provides medical imaging and radiation therapy for various diseases |
We are responsible for diagnostic imaging, interventional radiology (IVR) and radiation therapy for cancer. |
Our department consists of the diagnostic imaging group and the radiation therapy group. In the diagnostic imaging group, each specialist interprets radiological images CT, MRI, angiography, ultrasonography, and radioisotope (RI) examination and prepares diagnostic reports. In the radiation therapy group, each specialist plans and performs irradiation mainly for malignant tumors.
CT, MRI, RI (including PET), and IVR are performed for various diseases of the entire body such as inflammation, tumor, and congenital anomaly. In our hospital, ultrasonography is performed mainly for breast and thyroid disease. Radiation therapy is performed for many malignant tumors and a few benign diseases.
MRI diagnosis of inner ear diseases, CT diagnosis of biliary tract and pancreas, diagnostic imaging of the breast, PET diagnosis (including methionine), radioiodine therapy for thyroid cancer and hyperthyroidism, endovascular therapy of visceral artery aneurysm, diagnostic imaging of mammary glands, and high-precision radiation therapy.
The numbers of diagnostic imaging testing performed in 2011 are as follows: CT: 38,000; MRI: 17,000; ultrasonography: 3,800; RI / PET: 5,600; IVR: 550. We performed radiotherapy for 860 patients.
We provide medical care in the IVR outpatient clinic on Monday, Wednesday, and Friday morning, the outpatient clinic of radioiodine therapy for thyroid cancer on Tuesday morning, and the outpatient clinic of radioiodine therapy for hyperthyroidism on Thursday afternoon. Radiation therapy is performed by specialists every day in the outpatient clinic.
High-resolution MRI of the inner ear, virtual bronchoscopy, sentinel lymph node scintigraphy, PET using nuclides other than FDG, stereotactic lung irradiation in ultrasonography for nonpalpable mammary gland lesions, and prostate cancer IMRT.